Holen Sie sich die Stockscreener-App
7.965
1.21%
0.095
Schlusskurs vom Vortag:
$7.87
Offen:
$7.86
24-Stunden-Volumen:
9,289
Relative Volume:
0.32
Marktkapitalisierung:
$74.82M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-129.41M
KGV:
-0.3306
EPS:
-24.0922
Netto-Cashflow:
$-51.97M
1W Leistung:
+3.71%
1M Leistung:
-16.33%
6M Leistung:
+83.53%
1J Leistung:
+0.00%
1-Tages-Spanne:
$7.715
$8.275
1-Wochen-Bereich:
$7.33
$8.275
52-Wochen-Spanne:
$4.21
$14.21
Leonabio Inc Stock (LONA) Company Profile
Firmenname
Leonabio Inc
Sektor
Branche
Telefon
(425) 620-8501
Adresse
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL
Compare LONA vs VRTX, REGN, ARGX, RVMD, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LONA
Leonabio Inc
|
7.965 | 73.93M | 0 | -129.41M | -51.97M | -24.09 |
VRTX
Vertex Pharmaceuticals Inc
|
505.75 | 133.25B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.48 | 82.16B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
851.29 | 54.80B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
203.71 | 43.99B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
347.48 | 40.62B | 5.76B | 514.49M | 1.10B | 4.4813 |
Leonabio Inc Stock (LONA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-26 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2026-02-19 | Hochstufung | Mizuho | Neutral → Outperform |
| 2024-09-19 | Herabstufung | Mizuho | Outperform → Neutral |
| 2024-09-04 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-09-04 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-09-04 | Herabstufung | Rodman & Renshaw | Buy → Neutral |
| 2024-08-19 | Eingeleitet | Rodman & Renshaw | Buy |
| 2022-10-17 | Hochstufung | JMP Securities | Mkt Perform → Mkt Outperform |
| 2022-07-07 | Eingeleitet | Mizuho | Buy |
| 2022-06-23 | Herabstufung | JMP Securities | Mkt Outperform → Mkt Perform |
| 2022-06-23 | Herabstufung | Jefferies | Buy → Hold |
| 2022-06-23 | Herabstufung | Stifel | Buy → Hold |
| 2022-05-10 | Eingeleitet | BTIG Research | Buy |
| 2022-04-21 | Eingeleitet | Berenberg | Buy |
| 2021-12-15 | Eingeleitet | Goldman | Neutral |
| 2020-10-13 | Eingeleitet | Goldman | Buy |
| 2020-10-13 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2020-10-13 | Eingeleitet | Jefferies | Buy |
| 2020-10-13 | Eingeleitet | Stifel | Buy |
Alle ansehen
Leonabio Inc Aktie (LONA) Neueste Nachrichten
LeonaBio Q2 Results: EPS beats estimate, losses narrow 55% YoY - scanx.trade
LeonaBio Narrows Q2 Loss - marketscreener.com
LeonaBio Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times
LeonaBio (LONA) loss widens as cash burn rises and going concern risk emerges - Stock Titan
LeonaBio Q2 net loss widens on higher R&D spending - TradingView
LeonaBio Posts $19.0 Million Q2 Loss as ELAINE-3 Enrollment Advances - Quiver Quantitative
LeonaBio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
LeonaBio, Inc. (NASDAQ: LONA) Share Price, LONA Stock News, LONA Share Price & Updates - kalkine.ca
LeonaBio’s lasofoxifene to be featured at breast cancer summit By Investing.com - Investing.com Nigeria
LeonaBio’s lasofoxifene to be featured at breast cancer summit - Investing.com
LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer - The Manila Times
LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), - GlobeNewswire
LONA: LeonaBio, Inc.12 Month EPS - Zacks Investment Research
LeonaBio Inc expected to post a loss of $1.26 a shareEarnings Preview - TradingView
Citizens upgrades LeonaBio stock rating on breast cancer drug potential By Investing.com - Investing.com Canada
LeonaBio Inc. (LONA) Advances 2.08%: Biotech Stock Tests Mid-Range Resistance After Oversold BounceBreakaway Gap - dars.gov.et
LONA|LeonaBio Ord Shs|Price:7.275|Chg%:-0.115 - TradingKey
LeonaBio Ord Shs (LONA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LeonaBio Ord Shs (LONA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LeonaBio, Inc. Revenue Breakdown – NASDAQ:LONA - TradingView
LeonaBio Ord Shs (LONA) Institutional Confidence - TradingKey
LeonaBio Inc. (LONA) Drops 7.55% as Selling Pressure Intensifies, Testing Key SupportMomentum Stock Picks - dars.gov.et
Mizuho Securities Remains a Buy on LeonaBio (LONA) - The Globe and Mail
LONA Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Cost Discipline, Despite Revenue AbsenceEarnings Decline Risk - dars.gov.et
LeonaBio (LONA) Tumbles 8.4% as Stock Tests Key Support Levels Near $7.42Put Support - po-news-eg.net
LONA Q1 2026 Earnings: Beats EPS Estimates Amidst Pre-Revenue StageNet Profit Margin - dars.gov.et
LeonaBio Inc. (LONA) Gains 2.24% as Stock Approaches Key Resistance at $10.08Stop Loss Guidance - dars.gov.et
LONA Q1 2026 Earnings: Narrower-than-expected loss lifts sharesManagement Tone Analysis - dars.gov.et
Form 4 LeonaBio Inc For: 10 July By Investing.com - Investing.com Nigeria
LeonaBio (LONA) awards 28,000 stock options tied to Perceptive Advisors board role - Stock Titan
Form 4 LeonaBio Inc For: 9 July By Investing.com - Investing.com Nigeria
LeonaBio (LONA) director entities receive 28,000 stock options grant - Stock Titan
LeonaBio Inc. Q1 2026 Earnings: EPS Beat of 32.16% as Clinical Pipeline AdvancesGuidance Upgrade Report - dars.gov.et
LeonaBio (LONA) Gains 5.85% as Biotech Stock Approaches Key ResistanceIPO Entry Watch - dars.gov.et
LONA Q1 2026 Earnings: EPS Surprise of 32% Powers 5.85% Share RallyEarnings Per Share - dars.gov.et
LeonaBio Inc. (LONA) Declines 1.6% Amid Mixed Technical SignalsLow Vol ETF - dars.gov.et
LeonaBio, Inc.(NasdaqCM: LONA) added to Russell Microcap Growth Benchmark Index - marketscreener.com
LeonaBio, Inc.(NasdaqCM: LONA) added to Russell 3000E Growth Benchmark - marketscreener.com
LeonaBio, Inc.(NasdaqCM: LONA) added to Russell Microcap Index - marketscreener.com
LeonaBio, Inc.(NasdaqCM: LONA) added to Russell 3000E Index - marketscreener.com
LeonaBio Inc (LONA) Q1 2026 Earnings: EPS Beats Estimates by 32%, Stock Climbs 8%Earnings Surprise Score - dars.gov.et
LONALeonaBio Inc Dividends - Finviz
LONA SEC FilingsLeonaBio Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Enterprise value to EBIT forward of LeonaBio, Inc. – NASDAQ:LONA - TradingView
Price to sales forward of LeonaBio, Inc. – NASDAQ:LONA - TradingView
Number of shareholders of LeonaBio, Inc. – NASDAQ:LONA - TradingView
LeonaBio, Inc. Actuals & Estimates (NASDAQ:LONA) - TradingView
LONA Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 LeonaBio Inc For: 24 June By Investing.com - Investing.com South Africa
LeonaBio (LONA) director Fred Callori granted 2,333 stock options - Stock Titan
LeonaBio (LONA) director receives grant of 28,000 stock options at $8.35 - Stock Titan
Finanzdaten der Leonabio Inc-Aktie (LONA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):